Accesibilidad
Ayuda
Animación
Accesibilidad

LabCorp(R) Scheduled to Present at the SG Cowen 23rd Annual Health Care Conference

19 March 2003
BURLINGTON, N.C., Mar 19, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Bradford T. Smith, executive vice president of public affairs and licensing, is scheduled to speak at the SG COWEN 23RD Annual Health Care Conference in Boston, MA, on March 20, 2003, at 10:15 a.m. Eastern Time. At the conference, the Company will reiterate its guidance for 2003, as filed in an 8K on February 18, 2003. A live audio Webcast of the presentation will be available via the company Web site at www.labcorp.com. A replay of the audio Webcast will be available through September 20, 2003.

The first national clinical laboratory to fully embrace genomic testing, Laboratory Corporation of America(R) Holdings (LabCorp(R)) has been a pioneer in commercializing new diagnostic technologies. As a national laboratory with annual revenues of $2.5 billion in 2002 and over 24,000 employees, the Company offers more than 4,000 clinical tests ranging from routine analyses to sophisticated molecular diagnostics. Serving over 200,000 clients nationwide, LabCorp combines its expertise in innovative clinical testing technology with its Centers of Excellence. The Center for Molecular Biology and Pathology, in Research Triangle Park, North Carolina, offers state-of-the-art molecular gene-based testing in infectious disease, oncology and genetics. DIANON Systems, its Anatomic Pathology Center of Excellence, is a leader in oncology and genetic testing, and National Genetics Institute in Los Angeles is an industry leader in developing novel, highly sensitive polymerase chain reaction (PCR) methods for testing hepatitis C and other blood borne infectious agents. LabCorp's Minneapolis-based ViroMed offers molecular microbial testing using real time PCR platforms, while its Center for Esoteric Testing in Burlington, North Carolina, performs the largest volume of specialty testing in the network. LabCorp's clients include physicians, state and federal government, managed care organizations, hospitals, clinics, pharmaceutical and Fortune 1000 companies, and other clinical laboratories.

Each of the above forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace and adverse actions of governmental and other third-party payors. Actual results could differ materially from those suggested by these forward-looking statements. Further information on potential factors that could affect LabCorp's financial results is included in the Company's Form 10-K for the year ended December 31, 2001 and subsequent SEC filings, and will be available in its Form 10-K for the year ended December 31, 2002, when filed.

SOURCE Laboratory Corporation of America Holdings 

CONTACT:          Pamela Sherry of Laboratory Corporation of America
                  Holdings, +1-336-436-4855, or shareholder direct, +1-800-LAB-0401

URL:              http://www.labcorp.com 
http://www.prnewswire.com

Copyright (C) 2003 PR Newswire.  All rights reserved.